Founded in 2019, BeaMed (previously Squalus) aims to free the many pediatric and adult epilepsy patients, from the fear and devastating effects of epilepsy and to help them live a fulfilling and productive life. Introducing an innovative approach to epilepsy treatment using a new, patient specific, laser based thermal ablation technology for previously inoperable cases and by improving current procedure outcomes. The StingRay Laser System combines new fiber optic technology with an advanced laser console that allows a perfect match between the exact structure of the epileptic focal source and the energy delivery, while protecting vital functional areas against thermal damage. The console integrates computer vision analysis that guides the physician, making sure the treatment is adjusted to the specific patient and meets the clinical preplanned requirements.

Biotechnology

BT BeaMedical Technologies / BeaMed

Org chart

Teams

Offices

Similar companies